首页> 美国卫生研究院文献>Oncotarget >The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster
【2h】

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster

机译:RNA测序技术检测胰腺导管腺癌的microRNA表达特征:microRNA-216簇的抗肿瘤功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We analysed the RNA sequence-based microRNA (miRNA) signature of pancreatic ductal adenocarcinoma (PDAC). Aberrantly expressed miRNAs were successfully identified in this signature. Using the PDAC signature, we focused on 4 clustered miRNAs, miR-216a-5p, miR-216a-3p, miR-216b-5p and miR-216b-3p on human chromosome 2p16.1. All members of the miR-216 cluster were significantly reduced in PDAC specimens. Ectopic expression of these miRNAs suppressed cancer cell aggressiveness, suggesting miR-216 cluster as anti-tumour miRNAs in PDAC cells. The impact of miR-216b-3p (passenger strand of pre-miR-216b) on cancer cells is still ambiguous. Forkhead box Q1 (FOXQ1) was directly regulated by miR-216b-3p and overexpression of FOXQ1 was confirmed in clinical specimens. High expression of FOXQ1 predicted a shorter survival of patients with PDAC by Kaplan–Meier analysis. Loss-of-function assays showed that cancer cell migration and invasion activities were significantly reduced by siFOXQ1 transfectants. We investigated pathways downstream from FOXQ1 by using genome-wide gene expression analysis. Identification of the miR-216-3p/FOXQ1-mediated network in PDAC should enhance understanding of PDAC aggressiveness at the molecular level.
机译:我们分析了胰腺导管腺癌(PDAC)的基于RNA序列的microRNA(miRNA)签名。在此签名中成功识别出异常表达的miRNA。使用PDAC签名,我们集中研究了人类染色体2p16.1上的4个簇状miRNA,即miR-216a-5p,miR-216a-3p,miR-216b-5p和miR-216b-3p。在PDAC标本中,miR-216簇的所有成员均明显减少。这些miRNA的异位表达抑制了癌细胞的侵袭性,表明miR-216簇可作为PDAC细胞中的抗肿瘤miRNA。 miR-216b-3p(pre-miR-216b的乘客链)对癌细胞的影响仍然不明确。 miR-216b-3p直接调节了前叉箱Q1(FOXQ1),并在临床标本中证实了FOXQ1的过度表达。通过Kaplan–Meier分析,FOXQ1的高表达预测PDAC患者的生存期较短。功能丧失分析表明,siFOXQ1转染子显着降低了癌细胞的迁移和侵袭活性。我们通过使用全基因组基因表达分析调查了FOXQ1下游的途径。在PDAC中鉴定miR-216-3p / FOXQ1介导的网络应在分子水平上增强对PDAC攻击性的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号